Advertisement

Association of HLA-B51 with Clinical Expression of Behçet’s Disease

Analysis of 201 Iranian patients
  • F. Shahram
  • F. Davatchi
  • A. Nadji
  • A. Jamshidi
  • K. Bahar
  • M. Akbarian
  • F. Gharibdoost
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 528)

Keywords

Delay Effect Clinical Expression Present Sign Disease Expression Iranian Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lehner, T., 2000, Immunopathogenesis of Behçet’s disease. In Behçet’s Disease (D. Bang, E.-S. Lee, and S. Lee, eds.), Design Mecca Publishing Co., Seoul, pp. 3–18.Google Scholar
  2. 2.
    Krause, I., Molad, Y., and Weinberger, A., 1999, Association of HLA-B5 with clinical expression and severity of Behçet’s disease in Israel. J. Clin. Rheumatol. 5: 137–140.Google Scholar
  3. 3.
    Azizleri, G., Aksungur, V., Sarica, R., et al., 1994, The association of HLA-B5 antigen with specific manifestations of Behçet’s disease. Dermatology 188: 293–295.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • F. Shahram
    • 1
  • F. Davatchi
    • 1
  • A. Nadji
    • 1
  • A. Jamshidi
    • 1
  • K. Bahar
    • 1
  • M. Akbarian
    • 1
  • F. Gharibdoost
    • 1
  1. 1.Behçet’s Disease Unit, Rheumatology Research CenterTehran University for Medical Sciences, Shariati HospitalTehranIran

Personalised recommendations